Research Article

[Retracted] Identification of Gene-Tyrosine Kinase 2 (TYK2) in Head and Neck Squamous Cell Carcinoma Patients—An Integrated Bioinformatics Approach

Table 2

The logistic regression analysis showing the relationship between TYK2 and various clinicopathological variables.

CharacteristicsTotal ()Odds ratio (OR) value

T stage (T3 and T4 vs. T1 and T2)4870.924 (0.638-1.337)0.675
N stage (N1, N2, and N3 vs. N0)4801.142 (0.799-1.635)0.466
M stage (M1 vs. M0)4770.000 (NA-71235939037083215790857793373901009725996688748338538241225038652902251146688593920.000)0.992
Clinical stage (stage III and stage IV vs. stage I and stage II)4881.313 (0.863-2.004)0.205
Radiation therapy (no vs. yes)4410.739 (0.498-1.093)0.131
Primary therapy outcome (PD and SD vs. PR and CR)4180.485 (0.253-0.899)0.024
Gender (male vs. female)5021.707 (1.145-2.559)0.009
Race (Asian and Black or African American vs. White)4850.900 (0.515-1.566)0.709
Age (>60 vs. ≤60)5010.686 (0.482-0.975)0.036
Histologic grade (G3 and G4 vs. G1 and G2)4832.950 (1.918-4.604)<0.001
Smoker (yes vs. no)4920.933 (0.610-1.424)0.746
Alcohol history (yes vs. no)4911.446 (0.989-2.121)0.058
Lymphovascular invasion (yes vs. no)3411.181 (0.758-1.841)0.463
Lymph node neck dissection (no vs. yes)4991.061 (0.672-1.677)0.800